首页> 美国卫生研究院文献>Cancer Science >Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas
【2h】

Mitochondrial E3 ubiquitin ligase 1 promotes autophagy flux to suppress the development of clear cell renal cell carcinomas

机译:线粒体E3泛素连接酶1促进自噬通量抑制透明细胞肾细胞癌的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clear cell renal cell carcinoma (ccRCC) is one of the most common malignant tumors in the urinary system. Surgical intervention is the preferred treatment for ccRCC, but targeted biological therapy is required for postoperative recurrent or metastatic ccRCC. Autophagy is an intracellular degradation system for misfolded/aggregated proteins and dysfunctional organelles. Defective autophagy is associated with many diseases. Mul1 is a mitochondrion‐associated E3 ubiquitin ligase and involved in the regulation of divergent pathophysiological processes such as mitochondrial dynamics, and thus affects the development of various diseases including . Whether Mul1 regulates ccRCC development and what is the mechanism remain unclear. Histochemical staining and immunoblotting were used to analyze the levels of Mul1 protein in human renal tissues. Statistical analysis of information associated with tissue microarray and The Cancer Genome Atlas (TCGA) database was conducted to show the relationship between Mul1 expression and clinical features and survival of ccRCC patients. Impact of Mul1 on rates of cell growth and migration and autophagy flux were tested in cultured cancer cells. Herein we show that Mul1 promoted autophagy flux to facilitate the degradation of P62‐associated protein aggresomes and adipose differentiation‐related protein (ADFP)‐associated lipid droplets and suppressed the growth and migration of ccRCC cells. Levels of Mul1 protein and were significantly reduced so that autophagy flux was likely blocked in ccRCC tissues, which is potentially correlated with enhancement of malignancy of ccRCC and impairment of patient survival. Therefore, Mul1 may promote autophagy to suppress the development of cc .
机译:透明细胞肾细胞癌(ccRCC)是泌尿系统中最常见的恶性肿瘤之一。手术干预是ccRCC的首选治疗方法,但术后复发或转移性ccRCC需要靶向生物治疗。自噬是细胞内降解系统,用于错误折叠/聚集的蛋白质和功能细胞器。自噬缺陷与许多疾病有关。 Mul1是一种与线粒体相关的E3泛素连接酶,参与调节不同的病理生理过程,例如线粒体动力学,从而影响各种疾病的发展,包括。 Mul1是否调节ccRCC的发展以及其机制尚不清楚。用组织化学染色和免疫印迹法分析人肾组织中Mul1蛋白的水平。对与组织微阵列和癌症基因组图谱(TCGA)数据库有关的信息进行统计分析,以显示mul1表达与ccRCC患者临床特征和生存之间的关系。在培养的癌细胞中测试了Mul1对细胞生长和迁移速率以及自噬通量的影响。本文中我们显示Mul1促进自噬通量以促进P62相关蛋白聚集体和脂肪分化相关蛋白(ADFP)相关脂质滴的降解,并抑制ccRCC细胞的生长和迁移。 Mul1蛋白的水平显着降低,因此ccRCC组织中的自噬通量可能被阻断,这可能与ccRCC恶性程度的提高和患者存活率的降低有关。因此,Mul1可能促进自噬以抑制cc的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号